$29.81-0.84 (-2.74%)
Gen Digital Inc.
Gen Digital Inc. in the Technology sector is trading at $29.81 with a market capitalization of $14.9B. Wall Street consensus targets $33.00 (9 analysts), implying a +10.7% move over the next 12 months. The stock is currently near its 52-week high of $31.65, remaining 22.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.34B↑ | $1.28B↑ | $1.24B↑ | $1.22B↓ | $1.26B |
| Gross Profit | $1.03B↑ | $1.01B↑ | $972.00M↑ | $954.00M↓ | $990.00M |
| Operating Income | $475.00M↓ | $813.00M↑ | $444.00M↑ | $442.00M↓ | $456.00M |
| Net Income | $215.00M↓ | $512.00M↑ | $192.00M↑ | $134.00M↓ | $135.00M |
Gen Digital Inc. engages in the provision of cyber safety solutions for individuals, families, and small businesses. It offers security and performance management, identity protection, and online privacy, as well as technology platform. The company o...

The market is paying a premium valuation for a company delivering modest operational growth, betting that a major turnaround is just around the corner.

Here is how Exponent (EXPO) and Gen Digital (GEN) have performed compared to their sector so far this year.
Gen Digital Inc (NASDAQ:GEN) recently announced a total dividend of $0.13 per share, with the ex-dividend date set for 2026-08-17. This includes a $0.13 per share cash dividend payable on 2026-09-09. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.
GEN beats Q1 earnings and revenue estimates, posts double-digit bookings growth, and raises fiscal 2027 guidance as demand stays strong.
Moby summary of Gen Digital Inc.'s Q1 2027 earnings call
Academic risk and quality models computed from GEN's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 33.4% reading.
Fama-French 5-factor market beta. The five factors explain 17% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.